US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

InflaRx N.V.

1.72

+0.01000.58%

Post-market: 1.720.00000.00%19:52 EDT

Volume:422.16K

Turnover:738.46K

Market Cap:253.34M

PE:-3.16

High:1.80

Open:1.74

Low:1.72

Close:1.71

52wk High:2.95

52wk Low:0.7984

Shares:147.29M

Float Shares:98.11M

Volume Ratio:1.19

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5449

EPS(LYR):-0.7963

ROE:-38.52%

ROA:-18.54%

PB:1.54

PE(LYR):-2.16

Loading ...

Overview Company News Filings

Inflarx Weighs Broader Europe AAV Strategy, Plans EMA Talks on Vilobelimab and Izicopan

Palisade Bio adds Robert Baltera, Jordan Zwick to board of directors

InflaRx price target raised to $8 from $6 at H.C. Wainwright

InflaRx Is Maintained at Buy by HC Wainwright & Co.

InflaRx Is Maintained at Overweight by Cantor Fitzgerald

InflaRx closes USD 150 million follow-on offering of 75,000,000 shares at USD 2 each

Press Release: InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares

InflaRx to develop izicopan in AAV

Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing

InflaRx Gains on Plans for Kidney-Disorder Treatment, $150M Stock Offering

InflaRx prices 75,000,000-share offering at $2, raising $150 million

InflaRx targets izicopan development in ANCA-associated vasculitis, plans Phase 2 study

InflaRx Q1 2026 net loss narrows to €5.59 million; revenue flat at no revenue

InflaRx NV expected to post a loss of 14 cents a share - Earnings Preview

Analysts Are Bullish on These Healthcare Stocks: InflaRx (IFRX), Mirum Pharmaceuticals (MIRM)

InflaRx reports low reactive metabolite formation for izicopan in preclinical liver study

InflaRx NV expected to post a loss of 14 cents a share - Earnings Preview

InflaRx to report first-quarter results before market open, no conference call planned

InflaRx regains Nasdaq compliance after shares hold above $1 minimum bid price

InflaRx Price Target Maintained With a $14.00/Share by Guggenheim

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/IFRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IFRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IFRX\",,,,,undefined,":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":1.72,"timestamp":1790971200000,"preClose":1.71,"halted":0,"volume":422162,"hourTrading":{"tag":"盘后","latestPrice":1.72,"preClose":1.72,"latestTime":"19:52 EDT","volume":196,"amount":338.94,"timestamp":1790985157063,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005847953216374275,"floatShares":98114700,"shares":147292900,"eps":-0.544923,"marketStatus":"Closed","change":0.01,"latestTime":"10-02 16:00:00 EDT","open":1.74,"high":1.8,"low":1.72,"amount":738457.4220712,"amplitude":0.046784,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.544923,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1510117200000,"exchange":"NASDAQ","adjPreClose":1.71,"preHourTrading":{"tag":"盘前","latestPrice":1.75,"preClose":1.71,"latestTime":"08:46 EDT","volume":251,"amount":439.2699796,"timestamp":1790945218501,"change":0.04,"changeRate":0.023392,"amplitude":0.011696},"postHourTrading":{"tag":"盘后","latestPrice":1.72,"preClose":1.72,"latestTime":"19:52 EDT","volume":196,"amount":338.94,"timestamp":1790985157063,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.194473,"impliedVol":0.5179,"impliedVolPercentile":0.1315},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IFRX\",,,,,undefined,":{"symbol":"IFRX","floatShares":98114700,"roa":"-18.54%","roe":"-38.52%","lyrEps":-0.796269,"volumeRatio":1.194473,"shares":147292900,"dividePrice":0,"high":1.8,"amplitude":0.046784,"preClose":1.71,"low":1.72,"week52Low":0.7984,"pbRate":"1.54","psRate":"-22279.42","week52High":2.9489,"institutionHeld":0,"latestPrice":1.72,"eps":-0.544923,"divideRate":0,"volume":422162,"delay":0,"ttmEps":-0.544923,"open":1.74,"prevYearClose":1.01,"prevWeekClose":1.89,"prevMonthClose":1.8,"prevQuarterClose":1.8,"fiveDayClose":1.89,"twentyDayClose":2.23,"sixtyDayClose":2.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IFRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"IFRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.11},{"date":"2026-05-07","symbol":"IFRX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":-0.17,"defaultRemindTime":1778140800000,"name":null,"time":"Pre-MKt","dateTimestamp":1778126400000,"actualEps":null},{"market":"US","date":"2026-03-19","symbol":"IFRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.18,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2025-11-10","symbol":"IFRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2025-08-07","symbol":"IFRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.24,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IFRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IFRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1789444800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IFRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IFRX","date":"2026-10-01","current":-3.156409,"percent":0.123355,"low":-9.450046,"twenty":-4.184799,"median":-2.314372,"eighty":-1.540877,"high":-0.61166,"avg":-3.008306,"sd":2.035228,"marketCap":265262797},"quantilePoints":[{"date":"2021-10-08","current":-2.804412,"twenty":-25.638419,"median":-3.369345,"eighty":-2.139942,"marketCap":118861090},{"date":"2021-10-15","current":-2.568797,"twenty":-25.59942,"median":-3.355287,"eighty":-2.15103,"marketCap":109140109},{"date":"2021-10-22","current":-3.059811,"twenty":-25.561641,"median":-3.349052,"eighty":-2.154896,"marketCap":130349523},{"date":"2021-10-29","current":-4.423919,"twenty":-25.544343,"median":-3.348306,"eighty":-2.158087,"marketCap":187349822},{"date":"2021-11-05","current":-4.251839,"twenty":-25.536207,"median":-3.352563,"eighty":-2.163381,"marketCap":205466197},{"date":"2021-11-12","current":-5.149963,"twenty":-25.532701,"median":-3.369298,"eighty":-2.165514,"marketCap":246559436},{"date":"2021-11-19","current":-4.442446,"twenty":-25.494082,"median":-3.373909,"eighty":-2.169524,"marketCap":210326688},{"date":"2021-11-26","current":-4.743245,"twenty":-25.480025,"median":-3.383633,"eighty":-2.171417,"marketCap":224466297},{"date":"2021-12-03","current":-3.8471,"twenty":-25.476764,"median":-3.39115,"eighty":-2.172284,"marketCap":181605606},{"date":"2021-12-10","current":-3.950486,"twenty":-25.466679,"median":-3.407313,"eighty":-2.174154,"marketCap":186907960},{"date":"2021-12-17","current":-3.992006,"twenty":-25.456835,"median":-3.415357,"eighty":-2.176712,"marketCap":188233548},{"date":"2021-12-23","current":-4.34175,"twenty":-25.447224,"median":-3.439152,"eighty":-2.178157,"marketCap":205466197},{"date":"2021-12-31","current":-4.422329,"twenty":-25.434421,"median":-3.460422,"eighty":-2.181429,"marketCap":210326688},{"date":"2022-01-07","current":-3.615004,"twenty":-25.4299,"median":-3.469026,"eighty":-2.186377,"marketCap":171442762},{"date":"2022-01-14","current":-3.931443,"twenty":-25.423348,"median":-3.476311,"eighty":-2.188634,"marketCap":187791685},{"date":"2022-01-21","current":-3.27922,"twenty":-25.415798,"median":-3.480271,"eighty":-2.18983,"marketCap":155535702},{"date":"2022-01-28","current":-3.332032,"twenty":-25.405586,"median":-3.472316,"eighty":-2.191659,"marketCap":155535702},{"date":"2022-02-04","current":-3.277911,"twenty":-25.393185,"median":-3.463394,"eighty":-2.191987,"marketCap":156861290},{"date":"2022-02-11","current":-3.094239,"twenty":-25.349416,"median":-3.457906,"eighty":-2.192343,"marketCap":147582171},{"date":"2022-02-18","current":-2.908888,"twenty":-25.342061,"median":-3.438284,"eighty":-2.19268,"marketCap":137861190},{"date":"2022-02-25","current":-2.822869,"twenty":-25.330025,"median":-3.426102,"eighty":-2.193365,"marketCap":133000699},{"date":"2022-03-04","current":-2.042583,"twenty":-25.326961,"median":-3.408072,"eighty":-2.192509,"marketCap":93233048},{"date":"2022-03-11","current":-1.881926,"twenty":-25.319085,"median":-3.394102,"eighty":-2.189491,"marketCap":86163244},{"date":"2022-03-18","current":-2.091797,"twenty":-25.313085,"median":-3.389039,"eighty":-2.185207,"marketCap":96767951},{"date":"2022-03-25","current":-2.212947,"twenty":-25.309822,"median":-3.373909,"eighty":-2.178911,"marketCap":110951445},{"date":"2022-04-01","current":-1.667593,"twenty":-25.302123,"median":-3.369298,"eighty":-2.172439,"marketCap":83987149},{"date":"2022-04-08","current":-1.558658,"twenty":-25.300371,"median":-3.359638,"eighty":-2.164523,"marketCap":77356585},{"date":"2022-04-14","current":-1.613479,"twenty":-25.284057,"median":-3.352563,"eighty":-2.153506,"marketCap":79566773},{"date":"2022-04-22","current":-1.590703,"twenty":-25.274805,"median":-3.348306,"eighty":-2.139942,"marketCap":78240660},{"date":"2022-04-29","current":-1.553514,"twenty":-25.247442,"median":-3.341568,"eighty":-2.130135,"marketCap":74704359},{"date":"2022-05-06","current":-1.463033,"twenty":-25.232905,"median":-3.334919,"eighty":-2.118001,"marketCap":70726020},{"date":"2022-05-13","current":-1.158755,"twenty":-25.216013,"median":-3.326309,"eighty":-2.104355,"marketCap":64537493},{"date":"2022-05-20","current":-1.127654,"twenty":-25.153392,"median":-3.312666,"eighty":-2.090537,"marketCap":63653418},{"date":"2022-05-27","current":-1.133538,"twenty":-25.123387,"median":-3.307821,"eighty":-2.078473,"marketCap":64979531},{"date":"2022-06-03","current":-1.133052,"twenty":-25.102901,"median":-3.297547,"eighty":-2.071719,"marketCap":64979531},{"date":"2022-06-10","current":-1.099107,"twenty":-25.078955,"median":-3.285676,"eighty":-2.064881,"marketCap":61885268},{"date":"2022-06-17","current":-0.95534,"twenty":-25.058012,"median":-3.278566,"eighty":-2.059013,"marketCap":53486553},{"date":"2022-06-24","current":-0.61166,"twenty":-25.013779,"median":-3.274146,"eighty":-2.050697,"marketCap":34523138},{"date":"2022-07-01","current":-1.143714,"twenty":-24.953195,"median":-3.27019,"eighty":-2.039731,"marketCap":63653418},{"date":"2022-07-08","current":-1.249984,"twenty":-24.940061,"median":-3.266364,"eighty":-2.028029,"marketCap":68073795},{"date":"2022-07-15","current":-1.105244,"twenty":-24.912512,"median":-3.253607,"eighty":-2.016954,"marketCap":59675080},{"date":"2022-07-22","current":-1.090969,"twenty":-24.825431,"median":-3.232562,"eighty":-1.98678,"marketCap":59675080},{"date":"2022-07-29","current":-2.219243,"twenty":-24.705558,"median":-3.220144,"eighty":-1.924555,"marketCap":121118310},{"date":"2022-08-05","current":-3.310261,"twenty":-24.665355,"median":-3.208176,"eighty":-1.952888,"marketCap":128632950},{"date":"2022-08-12","current":-3.369138,"twenty":-24.623821,"median":-3.226312,"eighty":-1.980182,"marketCap":132169251},{"date":"2022-08-19","current":-2.876794,"twenty":-24.618574,"median":-3.208176,"eighty":-1.98678,"marketCap":110509407},{"date":"2022-08-26","current":-2.62393,"twenty":-24.606349,"median":-3.198154,"eighty":-2.009536,"marketCap":100342542},{"date":"2022-09-02","current":-2.648776,"twenty":-24.583084,"median":-3.186455,"eighty":-2.011689,"marketCap":101668654},{"date":"2022-09-09","current":-3.268037,"twenty":-24.575807,"median":-3.180921,"eighty":-2.016029,"marketCap":125538686},{"date":"2022-09-16","current":-3.112552,"twenty":-24.525387,"median":-3.168258,"eighty":-2.016818,"marketCap":119350160},{"date":"2022-09-23","current":-2.519124,"twenty":-24.51136,"median":-3.149642,"eighty":-2.017498,"marketCap":93711977},{"date":"2022-09-30","current":-3.110486,"twenty":-24.503768,"median":-3.141488,"eighty":-2.023142,"marketCap":116697934},{"date":"2022-10-07","current":-3.001762,"twenty":-24.499937,"median":-3.125003,"eighty":-2.026815,"marketCap":112277558},{"date":"2022-10-14","current":-2.833329,"twenty":-24.463679,"median":-3.11616,"eighty":-2.027695,"marketCap":105646993},{"date":"2022-10-21","current":-2.968518,"twenty":-24.434266,"median":-3.112552,"eighty":-2.029366,"marketCap":111393482},{"date":"2022-10-28","current":-3.044242,"twenty":-24.387783,"median":-3.104843,"eighty":-2.031686,"marketCap":115813859},{"date":"2022-11-04","current":-2.925419,"twenty":-24.386265,"median":-3.100143,"eighty":-2.034524,"marketCap":110951445},{"date":"2022-11-11","current":-3.360927,"twenty":-24.374133,"median":-3.104843,"eighty":-2.038158,"marketCap":118466084},{"date":"2022-11-18","current":-3.187327,"twenty":-24.357612,"median":-3.106216,"eighty":-2.04209,"marketCap":112719595},{"date":"2022-11-25","current":-3.114145,"twenty":-24.321314,"median":-3.103471,"eighty":-2.042484,"marketCap":110509407},{"date":"2022-12-02","current":-3.199416,"twenty":-24.305952,"median":-3.109484,"eighty":-2.045113,"marketCap":114487746},{"date":"2022-12-09","current":-2.839171,"twenty":-24.296418,"median":-3.103471,"eighty":-2.048262,"marketCap":102110692},{"date":"2022-12-16","current":-2.626368,"twenty":-24.268656,"median":-3.098225,"eighty":-2.052502,"marketCap":95038090},{"date":"2022-12-23","current":-3.963354,"twenty":-24.249087,"median":-3.100143,"eighty":-2.05414,"marketCap":143662229},{"date":"2022-12-30","current":-3.757141,"twenty":-24.236402,"median":-3.103471,"eighty":-2.05494,"marketCap":137031665},{"date":"2023-01-06","current":-3.429325,"twenty":-24.187068,"median":-3.103471,"eighty":-2.05494,"marketCap":124212574},{"date":"2023-01-13","current":-3.148676,"twenty":-24.119807,"median":-3.103471,"eighty":-2.05494,"marketCap":116255896},{"date":"2023-01-20","current":-2.87463,"twenty":-24.060794,"median":-3.095243,"eighty":-2.05494,"marketCap":106310050},{"date":"2023-01-27","current":-2.684699,"twenty":-23.889509,"median":-3.081171,"eighty":-2.05494,"marketCap":99458466},{"date":"2023-02-03","current":-2.625894,"twenty":-23.753924,"median":-3.075373,"eighty":-2.05494,"marketCap":97248278},{"date":"2023-02-10","current":-2.437904,"twenty":-23.637734,"median":-3.064648,"eighty":-2.05494,"marketCap":88849563},{"date":"2023-02-17","current":-2.733077,"twenty":-23.443338,"median":-3.059811,"eighty":-2.05494,"marketCap":99458466},{"date":"2023-02-24","current":-2.504414,"twenty":-23.240436,"median":-3.05296,"eighty":-2.05494,"marketCap":90175676},{"date":"2023-03-03","current":-2.223958,"twenty":-23.091745,"median":-3.042742,"eighty":-2.05494,"marketCap":80450848},{"date":"2023-03-10","current":-2.185996,"twenty":-22.971614,"median":-3.031527,"eighty":-2.05494,"marketCap":79566773},{"date":"2023-03-17","current":-2.017049,"twenty":-22.749108,"median":-3.015708,"eighty":-2.053956,"marketCap":73378246},{"date":"2023-03-24","current":-2.536982,"twenty":-22.567429,"median":-3.002572,"eighty":-2.051599,"marketCap":80466773},{"date":"2023-03-31","current":-2.707242,"twenty":-22.293774,"median":-2.985327,"eighty":-2.052502,"marketCap":86725300},{"date":"2023-04-06","current":-8.468992,"twenty":-22.221188,"median":-2.980368,"eighty":-2.050697,"marketCap":272692954},{"date":"2023-04-19","current":-7.539816,"twenty":-21.900043,"median":-2.966913,"eighty":-2.045113,"marketCap":243679193},{"date":"2023-04-28","current":-8.425592,"twenty":-21.574969,"median":-2.964258,"eighty":-2.043848,"marketCap":273807214},{"date":"2023-05-05","current":-8.149129,"twenty":-21.326308,"median":-2.964258,"eighty":-2.043848,"marketCap":264385891},{"date":"2023-05-12","current":-8.961759,"twenty":-21.165358,"median":-2.964258,"eighty":-2.043848,"marketCap":288528032},{"date":"2023-05-19","current":-8.105007,"twenty":-20.576815,"median":-2.964258,"eighty":-2.043848,"marketCap":257319898},{"date":"2023-05-26","current":-7.634536,"twenty":-18.895891,"median":-2.964258,"eighty":-2.043848,"marketCap":241421415},{"date":"2023-06-02","current":-8.897592,"twenty":-17.2313,"median":-2.964258,"eighty":-2.043848,"marketCap":253786902},{"date":"2023-06-09","current":-8.238655,"twenty":-8.997075,"median":-2.964258,"eighty":-2.043848,"marketCap":235827504},{"date":"2023-06-16","current":-9.028798,"twenty":-8.93681,"median":-2.964258,"eighty":-2.043848,"marketCap":262030560},{"date":"2023-06-23","current":-9.140768,"twenty":-8.899027,"median":-2.963209,"eighty":-2.043216,"marketCap":266152389},{"date":"2023-06-30","current":-9.039015,"twenty":-8.897592,"median":-2.962755,"eighty":-2.042583,"marketCap":261441727},{"date":"2023-07-07","current":-7.957828,"twenty":-8.77461,"median":-2.962755,"eighty":-2.042583,"marketCap":229644760},{"date":"2023-07-14","current":-8.574185,"twenty":-8.60592,"median":-2.962755,"eighty":-2.042583,"marketCap":254964567},{"date":"2023-07-21","current":-8.113503,"twenty":-8.47995,"median":-2.962755,"eighty":-2.042583,"marketCap":240243749},{"date":"2023-07-28","current":-8.208184,"twenty":-8.435717,"median":-2.962755,"eighty":-2.042583,"marketCap":239654917},{"date":"2023-08-04","current":-8.299584,"twenty":-8.360313,"median":-2.962755,"eighty":-2.042583,"marketCap":241421415},{"date":"2023-08-11","current":-6.068497,"twenty":-8.239877,"median":-2.962755,"eighty":-2.042583,"marketCap":235533088},{"date":"2023-08-18","current":-5.82274,"twenty":-8.188318,"median":-2.962755,"eighty":-2.042583,"marketCap":223167600},{"date":"2023-08-25","current":-5.909797,"twenty":-8.105007,"median":-2.962755,"eighty":-2.042583,"marketCap":225522931},{"date":"2023-09-01","current":-6.086379,"twenty":-7.942756,"median":-2.962301,"eighty":-2.042484,"marketCap":232588924},{"date":"2023-09-08","current":-6.122042,"twenty":-7.841561,"median":-2.962301,"eighty":-2.042484,"marketCap":230822426},{"date":"2023-09-15","current":-6.047691,"twenty":-7.657546,"median":-2.962301,"eighty":-2.042484,"marketCap":227289429},{"date":"2023-09-22","current":-4.87418,"twenty":-7.215475,"median":-2.960275,"eighty":-2.042386,"marketCap":183126975},{"date":"2023-09-29","current":-4.665817,"twenty":-6.271729,"median":-2.960275,"eighty":-2.042386,"marketCap":173705652},{"date":"2023-10-06","current":-4.095273,"twenty":-6.07565,"median":-2.960275,"eighty":-2.042386,"marketCap":151918841},{"date":"2023-10-13","current":-3.864893,"twenty":-5.857563,"median":-2.960275,"eighty":-2.042386,"marketCap":143675183},{"date":"2023-10-20","current":-3.286668,"twenty":-5.646626,"median":-2.960275,"eighty":-2.042386,"marketCap":122477205},{"date":"2023-10-27","current":-2.697868,"twenty":-5.537504,"median":-2.950514,"eighty":-2.04209,"marketCap":100101562},{"date":"2023-11-03","current":-2.233806,"twenty":-5.197421,"median":-2.928023,"eighty":-2.04209,"marketCap":82436580},{"date":"2023-11-10","current":-2.087155,"twenty":-4.907963,"median":-2.91242,"eighty":-2.04209,"marketCap":77725919},{"date":"2023-11-17","current":-2.261025,"twenty":-4.743245,"median":-2.905286,"eighty":-2.034524,"marketCap":85380744},{"date":"2023-11-24","current":-2.252183,"twenty":-4.665817,"median":-2.892865,"eighty":-2.034524,"marketCap":85380744},{"date":"2023-12-01","current":-2.096632,"twenty":-4.532206,"median":-2.879719,"eighty":-2.031686,"marketCap":79492417},{"date":"2023-12-08","current":-2.197999,"twenty":-4.48737,"median":-2.868186,"eighty":-2.032254,"marketCap":82436580},{"date":"2023-12-15","current":-2.110521,"twenty":-4.438457,"median":-2.833849,"eighty":-2.032254,"marketCap":80670082},{"date":"2023-12-22","current":-2.280481,"twenty":-4.370666,"median":-2.82501,"eighty":-2.031763,"marketCap":87147242},{"date":"2023-12-29","current":-2.538435,"twenty":-4.33424,"median":-2.816208,"eighty":-2.031686,"marketCap":97746231},{"date":"2024-01-05","current":-2.828463,"twenty":-4.286188,"median":-2.805171,"eighty":-2.031222,"marketCap":107756387},{"date":"2024-01-12","current":-2.707482,"twenty":-4.256229,"median":-2.79763,"eighty":-2.031222,"marketCap":103045726},{"date":"2024-01-19","current":-2.494382,"twenty":-4.232858,"median":-2.773571,"eighty":-2.030758,"marketCap":94213235},{"date":"2024-01-26","current":-2.344327,"twenty":-4.195043,"median":-2.765202,"eighty":-2.031222,"marketCap":88324908},{"date":"2024-02-02","current":-2.654313,"twenty":-4.16251,"median":-2.743527,"eighty":-2.031222,"marketCap":100101562},{"date":"2024-02-09","current":-2.486219,"twenty":-4.136824,"median":-2.732222,"eighty":-2.031222,"marketCap":93035569},{"date":"2024-02-16","current":-2.42458,"twenty":-4.095212,"median":-2.710198,"eighty":-2.031222,"marketCap":90680238},{"date":"2024-02-23","current":-2.301923,"twenty":-4.077605,"median":-2.703082,"eighty":-2.031222,"marketCap":86558409},{"date":"2024-03-01","current":-2.789171,"twenty":-4.072563,"median":-2.697868,"eighty":-2.031686,"marketCap":104812224},{"date":"2024-03-08","current":-2.572738,"twenty":-4.024419,"median":-2.697241,"eighty":-2.031686,"marketCap":97746231},{"date":"2024-03-15","current":-2.363742,"twenty":-4.006418,"median":-2.688162,"eighty":-2.031686,"marketCap":89502573},{"date":"2024-03-22","current":-1.957166,"twenty":-3.989235,"median":-2.683334,"eighty":-2.029366,"marketCap":90680238},{"date":"2024-03-28","current":-1.96758,"twenty":-3.977045,"median":-2.670879,"eighty":-2.026815,"marketCap":90680238},{"date":"2024-04-05","current":-1.981938,"twenty":-3.964341,"median":-2.658011,"eighty":-2.01666,"marketCap":91857904},{"date":"2024-04-12","current":-1.984369,"twenty":-3.932271,"median":-2.654637,"eighty":-1.983883,"marketCap":90680238},{"date":"2024-04-19","current":-1.630704,"twenty":-3.866737,"median":-2.638291,"eighty":-1.97026,"marketCap":74192922},{"date":"2024-04-26","current":-1.790703,"twenty":-3.836036,"median":-2.634291,"eighty":-1.962479,"marketCap":81847748},{"date":"2024-05-03","current":-1.780105,"twenty":-3.78565,"median":-2.628724,"eighty":-1.946126,"marketCap":81258915},{"date":"2024-05-10","current":-1.590155,"twenty":-3.773538,"median":-2.625321,"eighty":-1.897734,"marketCap":70659926},{"date":"2024-05-17","current":-1.904668,"twenty":-3.753351,"median":-2.61868,"eighty":-1.886655,"marketCap":85380744},{"date":"2024-05-24","current":-1.952316,"twenty":-3.735549,"median":-2.606627,"eighty":-1.886655,"marketCap":87147242},{"date":"2024-05-31","current":-1.882889,"twenty":-3.684127,"median":-2.593785,"eighty":-1.882889,"marketCap":84203078},{"date":"2024-06-07","current":-2.112539,"twenty":-3.653656,"median":-2.588348,"eighty":-1.881926,"marketCap":94802067},{"date":"2024-06-14","current":-2.016149,"twenty":-3.654543,"median":-2.588093,"eighty":-1.881261,"marketCap":89502573},{"date":"2024-06-21","current":-1.971968,"twenty":-3.65543,"median":-2.585869,"eighty":-1.880596,"marketCap":87147242},{"date":"2024-06-28","current":-2.227273,"twenty":-3.658092,"median":-2.588093,"eighty":-1.878601,"marketCap":98335064},{"date":"2024-07-05","current":-2.152746,"twenty":-3.658092,"median":-2.584246,"eighty":-1.878601,"marketCap":95979733},{"date":"2024-07-12","current":-2.154011,"twenty":-3.658092,"median":-2.579459,"eighty":-1.878601,"marketCap":96568566},{"date":"2024-07-15","current":-2.132266,"twenty":-3.658092,"median":-2.579459,"eighty":-1.878601,"marketCap":95979733},{"date":"2024-08-02","current":-2.012243,"twenty":-3.698487,"median":-2.587838,"eighty":-1.867194,"marketCap":89502573},{"date":"2024-08-09","current":-1.542577,"twenty":-3.698487,"median":-2.587838,"eighty":-1.851127,"marketCap":78903584},{"date":"2024-08-16","current":-1.543577,"twenty":-3.698487,"median":-2.587838,"eighty":-1.84579,"marketCap":79492417},{"date":"2024-08-23","current":-1.707365,"twenty":-3.698487,"median":-2.587838,"eighty":-1.84579,"marketCap":88913740},{"date":"2024-08-30","current":-1.882183,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":97746231},{"date":"2024-09-06","current":-1.77856,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":92446737},{"date":"2024-09-13","current":-1.638886,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":84791911},{"date":"2024-09-20","current":-1.7139,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":89502573},{"date":"2024-09-27","current":-1.730455,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":90680238},{"date":"2024-10-04","current":-1.77879,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":91857904},{"date":"2024-10-11","current":-1.678334,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":85969577},{"date":"2024-10-18","current":-1.797756,"twenty":-3.698487,"median":-2.587838,"eighty":-1.847445,"marketCap":91269071},{"date":"2024-10-25","current":-1.86037,"twenty":-3.698487,"median":-2.587838,"eighty":-1.849356,"marketCap":94213235},{"date":"2024-10-31","current":-1.816024,"twenty":-3.698487,"median":-2.587838,"eighty":-1.849356,"marketCap":92446737},{"date":"2024-11-08","current":-1.75819,"twenty":-3.703273,"median":-2.588093,"eighty":-1.853721,"marketCap":88913740},{"date":"2024-11-15","current":-1.986236,"twenty":-3.703273,"median":-2.588093,"eighty":-1.85898,"marketCap":119533042},{"date":"2024-11-22","current":-2.032862,"twenty":-3.703273,"median":-2.588093,"eighty":-1.873049,"marketCap":121299540},{"date":"2024-11-29","current":-2.413842,"twenty":-3.703273,"median":-2.588093,"eighty":-1.881058,"marketCap":144852849},{"date":"2024-12-06","current":-2.409258,"twenty":-3.703273,"median":-2.588093,"eighty":-1.888141,"marketCap":144852849},{"date":"2024-12-13","current":-2.279807,"twenty":-3.703273,"median":-2.588093,"eighty":-1.905561,"marketCap":136020358},{"date":"2024-12-20","current":-2.123768,"twenty":-3.703273,"median":-2.588093,"eighty":-1.919808,"marketCap":125421369},{"date":"2024-12-27","current":-2.594259,"twenty":-3.703273,"median":-2.590889,"eighty":-1.928389,"marketCap":153685339},{"date":"2025-01-03","current":-2.523482,"twenty":-3.703273,"median":-2.593524,"eighty":-1.945481,"marketCap":147208180},{"date":"2025-01-10","current":-2.342961,"twenty":-3.70806,"median":-2.593617,"eighty":-1.957166,"marketCap":137198023},{"date":"2025-01-17","current":-2.564185,"twenty":-3.70806,"median":-2.593617,"eighty":-1.96758,"marketCap":150152343},{"date":"2025-01-24","current":-2.356442,"twenty":-3.70806,"median":-2.593617,"eighty":-1.978631,"marketCap":139553354},{"date":"2025-01-31","current":-2.353498,"twenty":-3.70806,"median":-2.593617,"eighty":-1.994331,"marketCap":139553354},{"date":"2025-02-07","current":-2.534146,"twenty":-3.70806,"median":-2.593617,"eighty":-2.012243,"marketCap":149563510},{"date":"2025-02-14","current":-2.676169,"twenty":-3.70806,"median":-2.594259,"eighty":-2.017073,"marketCap":158984834},{"date":"2025-02-21","current":-1.830033,"twenty":-3.70806,"median":-2.594259,"eighty":-2.016149,"marketCap":108934053},{"date":"2025-02-28","current":-1.342976,"twenty":-3.70806,"median":-2.594259,"eighty":-2.007413,"marketCap":79492417},{"date":"2025-03-07","current":-1.156608,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":71248759},{"date":"2025-03-14","current":-1.095804,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":67715762},{"date":"2025-03-21","current":-1.484361,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":74192922},{"date":"2025-03-28","current":-1.699421,"twenty":-3.708133,"median":-2.594022,"eighty":-1.983883,"marketCap":84502137},{"date":"2025-04-04","current":-1.392072,"twenty":-3.708133,"median":-2.593524,"eighty":-1.978954,"marketCap":70981795},{"date":"2025-04-11","current":-1.180921,"twenty":-3.70806,"median":-2.588348,"eighty":-1.96758,"marketCap":60841539},{"date":"2025-04-17","current":-1.355089,"twenty":-3.70806,"median":-2.587838,"eighty":-1.958598,"marketCap":70981795},{"date":"2025-04-25","current":-1.706059,"twenty":-3.708133,"median":-2.586854,"eighty":-1.944521,"marketCap":89234257},{"date":"2025-05-02","current":-2.407629,"twenty":-3.708133,"median":-2.583083,"eighty":-1.926392,"marketCap":125063163},{"date":"2025-05-09","current":-2.118244,"twenty":-3.708133,"median":-2.577703,"eighty":-1.926392,"marketCap":106810701},{"date":"2025-05-16","current":-2.410655,"twenty":-3.708133,"median":-2.573155,"eighty":-1.926392,"marketCap":120589891},{"date":"2025-05-23","current":-2.443597,"twenty":-3.679696,"median":-2.568267,"eighty":-1.926392,"marketCap":123299776},{"date":"2025-05-30","current":-1.13339,"twenty":-3.647428,"median":-2.563851,"eighty":-1.913307,"marketCap":57591835},{"date":"2025-06-06","current":-1.123178,"twenty":-3.626423,"median":-2.55507,"eighty":-1.889126,"marketCap":57517313},{"date":"2025-06-13","current":-1.047083,"twenty":-3.626423,"median":-2.541295,"eighty":-1.880393,"marketCap":54197704},{"date":"2025-06-20","current":-1.054136,"twenty":-3.62668,"median":-2.538033,"eighty":-1.875322,"marketCap":54062209},{"date":"2025-06-27","current":-1.078148,"twenty":-3.62668,"median":-2.538033,"eighty":-1.847382,"marketCap":56406260},{"date":"2025-07-03","current":-1.03345,"twenty":-3.62668,"median":-2.538033,"eighty":-1.835407,"marketCap":54360297},{"date":"2025-07-11","current":-1.160295,"twenty":-3.62668,"median":-2.538033,"eighty":-1.822354,"marketCap":60647230},{"date":"2025-07-18","current":-1.134508,"twenty":-3.62668,"median":-2.538033,"eighty":-1.809629,"marketCap":58797734},{"date":"2025-07-25","current":-1.094112,"twenty":-3.62668,"median":-2.538033,"eighty":-1.799033,"marketCap":57591835},{"date":"2025-08-01","current":-1.198497,"twenty":-3.62668,"median":-2.538033,"eighty":-1.790625,"marketCap":61311152},{"date":"2025-08-08","current":-1.048287,"twenty":-3.62668,"median":-2.538033,"eighty":-1.779579,"marketCap":55220685},{"date":"2025-08-15","current":-1.062121,"twenty":-3.62668,"median":-2.538033,"eighty":-1.773402,"marketCap":56047200},{"date":"2025-08-22","current":-1.15665,"twenty":-3.62668,"median":-2.538033,"eighty":-1.764837,"marketCap":60836922},{"date":"2025-08-29","current":-1.500694,"twenty":-3.62668,"median":-2.538033,"eighty":-1.751777,"marketCap":79264142},{"date":"2025-09-05","current":-2.017509,"twenty":-3.626938,"median":-2.538234,"eighty":-1.751639,"marketCap":106362994},{"date":"2025-09-12","current":-1.872294,"twenty":-3.62668,"median":-2.538033,"eighty":-1.751777,"marketCap":99588281},{"date":"2025-09-19","current":-1.738574,"twenty":-3.62668,"median":-2.538033,"eighty":-1.741257,"marketCap":92813568},{"date":"2025-09-26","current":-1.652681,"twenty":-3.62668,"median":-2.538033,"eighty":-1.733002,"marketCap":87393797},{"date":"2025-10-03","current":-1.764269,"twenty":-3.62668,"median":-2.538033,"eighty":-1.729865,"marketCap":93491039},{"date":"2025-10-10","current":-1.888603,"twenty":-3.62668,"median":-2.538033,"eighty":-1.729865,"marketCap":98910809},{"date":"2025-10-17","current":-1.589181,"twenty":-3.62668,"median":-2.538033,"eighty":-1.715896,"marketCap":84006441},{"date":"2025-10-24","current":-1.572126,"twenty":-3.62668,"median":-2.538033,"eighty":-1.710768,"marketCap":82651498},{"date":"2025-10-31","current":-1.707503,"twenty":-3.62668,"median":-2.536982,"eighty":-1.708857,"marketCap":89426211},{"date":"2025-11-07","current":-1.555866,"twenty":-3.62668,"median":-2.534146,"eighty":-1.707448,"marketCap":81296556},{"date":"2025-11-14","current":-1.842931,"twenty":-3.62668,"median":-2.532153,"eighty":-1.706843,"marketCap":86038855},{"date":"2025-11-21","current":-1.683561,"twenty":-3.62668,"median":-2.529404,"eighty":-1.704879,"marketCap":77909199},{"date":"2025-11-28","current":-1.835231,"twenty":-3.62668,"median":-2.52731,"eighty":-1.704879,"marketCap":85361383},{"date":"2025-12-05","current":-1.593453,"twenty":-3.62668,"median":-2.52731,"eighty":-1.699337,"marketCap":74521843},{"date":"2025-12-12","current":-1.46602,"twenty":-3.62668,"median":-2.519124,"eighty":-1.679502,"marketCap":69102072},{"date":"2025-12-19","current":-1.524944,"twenty":-3.62668,"median":-2.509756,"eighty":-1.667406,"marketCap":71811957},{"date":"2025-12-26","current":-1.634642,"twenty":-3.62668,"median":-2.502779,"eighty":-1.658358,"marketCap":77231728},{"date":"2026-01-02","current":-1.452671,"twenty":-3.62668,"median":-2.494862,"eighty":-1.654063,"marketCap":68424601},{"date":"2026-01-09","current":-1.580071,"twenty":-3.62668,"median":-2.49125,"eighty":-1.646849,"marketCap":73844371},{"date":"2026-01-16","current":-1.455182,"twenty":-3.615874,"median":-2.479169,"eighty":-1.636099,"marketCap":67747130},{"date":"2026-01-23","current":-1.480915,"twenty":-3.615874,"median":-2.472232,"eighty":-1.62913,"marketCap":69779543},{"date":"2026-01-30","current":-1.306377,"twenty":-3.615874,"median":-2.463946,"eighty":-1.611667,"marketCap":62510276},{"date":"2026-02-06","current":-1.182562,"twenty":-3.615874,"median":-2.454336,"eighty":-1.599547,"marketCap":55918481},{"date":"2026-02-13","current":-1.183431,"twenty":-3.615874,"median":-2.437007,"eighty":-1.592464,"marketCap":56318189},{"date":"2026-02-20","current":-1.253127,"twenty":-3.593673,"median":-2.426574,"eighty":-1.590155,"marketCap":59129695},{"date":"2026-02-27","current":-1.333814,"twenty":-3.582235,"median":-2.418167,"eighty":-1.586876,"marketCap":63092902},{"date":"2026-03-06","current":-1.344198,"twenty":-3.559755,"median":-2.407629,"eighty":-1.575542,"marketCap":62334134},{"date":"2026-03-13","current":-1.437495,"twenty":-3.516775,"median":-2.396656,"eighty":-1.571306,"marketCap":66453159},{"date":"2026-03-20","current":-1.170912,"twenty":-3.481466,"median":-2.375348,"eighty":-1.561292,"marketCap":61622789},{"date":"2026-03-27","current":-1.277353,"twenty":-3.462757,"median":-2.363742,"eighty":-1.557873,"marketCap":67232358},{"date":"2026-04-02","current":-1.239124,"twenty":-3.455746,"median":-2.356018,"eighty":-1.553395,"marketCap":65280451},{"date":"2026-04-10","current":-1.394796,"twenty":-3.431158,"median":-2.353016,"eighty":-1.543577,"marketCap":74461644},{"date":"2026-04-17","current":-1.614359,"twenty":-3.363623,"median":-2.3395,"eighty":-1.541148,"marketCap":86751430},{"date":"2026-04-24","current":-2.109788,"twenty":-3.344491,"median":-2.322895,"eighty":-1.541148,"marketCap":112776860},{"date":"2026-05-01","current":-2.795263,"twenty":-3.321769,"median":-2.31439,"eighty":-1.541148,"marketCap":149646218},{"date":"2026-05-08","current":-3.792913,"twenty":-3.30237,"median":-2.31439,"eighty":-1.541148,"marketCap":191576076},{"date":"2026-05-15","current":-6.998494,"twenty":-3.321769,"median":-2.31439,"eighty":-1.541148,"marketCap":350557004},{"date":"2026-05-22","current":-7.317402,"twenty":-3.339281,"median":-2.31439,"eighty":-1.541148,"marketCap":363813361},{"date":"2026-05-29","current":-7.00993,"twenty":-3.34626,"median":-2.314381,"eighty":-1.541012,"marketCap":350557004},{"date":"2026-06-05","current":-5.905114,"twenty":-3.362489,"median":-2.31439,"eighty":-1.541148,"marketCap":294585718},{"date":"2026-06-12","current":-5.004121,"twenty":-3.362489,"median":-2.31439,"eighty":-1.541148,"marketCap":247452003},{"date":"2026-06-18","current":-5.442995,"twenty":-3.362489,"median":-2.31439,"eighty":-1.541148,"marketCap":268073003},{"date":"2026-06-26","current":-5.60795,"twenty":-3.359109,"median":-2.314381,"eighty":-1.541012,"marketCap":273964717},{"date":"2026-07-02","current":-6.988224,"twenty":-3.359109,"median":-2.314381,"eighty":-1.541012,"marketCap":343192361},{"date":"2026-07-10","current":-6.185501,"twenty":-3.36855,"median":-2.314381,"eighty":-1.541012,"marketCap":303423289},{"date":"2026-07-17","current":-5.730511,"twenty":-3.441547,"median":-2.314381,"eighty":-1.541012,"marketCap":281329360},{"date":"2026-07-24","current":-5.222528,"twenty":-3.469688,"median":-2.314381,"eighty":-1.541012,"marketCap":254816646},{"date":"2026-07-31","current":-5.127989,"twenty":-3.54332,"median":-2.314372,"eighty":-1.540877,"marketCap":253343717},{"date":"2026-08-07","current":-5.616396,"twenty":-3.652622,"median":-2.314372,"eighty":-1.540877,"marketCap":253343717},{"date":"2026-08-14","current":-6.559138,"twenty":-3.743947,"median":-2.314372,"eighty":-1.540877,"marketCap":296210124},{"date":"2026-08-21","current":-6.51116,"twenty":-3.79146,"median":-2.314372,"eighty":-1.540877,"marketCap":297683806},{"date":"2026-08-28","current":-7.335799,"twenty":-3.872268,"median":-2.314372,"eighty":-1.540877,"marketCap":334525861},{"date":"2026-09-04","current":-7.223324,"twenty":-3.96078,"median":-2.314372,"eighty":-1.540877,"marketCap":328631132},{"date":"2026-09-11","current":-6.637188,"twenty":-3.989551,"median":-2.314372,"eighty":-1.540877,"marketCap":302104853},{"date":"2026-09-18","current":-6.754873,"twenty":-4.051471,"median":-2.314372,"eighty":-1.540877,"marketCap":303578535},{"date":"2026-09-25","current":-6.391081,"twenty":-4.118783,"median":-2.314372,"eighty":-1.540877,"marketCap":284420666},{"date":"2026-10-01","current":-6.018872,"twenty":-4.184799,"median":-2.314372,"eighty":-1.540877,"marketCap":265262797}],"updateTime":1790986471556},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IFRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647955860","title":"Inflarx Weighs Broader Europe AAV Strategy, Plans EMA Talks on Vilobelimab and Izicopan","url":"https://stock-news.laohu8.com/highlight/detail?id=2647955860","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647955860?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:30","pubTimestamp":1782819055,"startTime":"0","endTime":"0","summary":"InflaRx weighs broader Europe AAV strategy, plans EMA talks on vilobelimab and izicopanInflaRx is weighing a broader Europe development and registration strategy for ANCA-associated vasculitis followi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL8mFq5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","IFRX","IE00BKPKM429.USD","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642284087","title":"Palisade Bio adds Robert Baltera, Jordan Zwick to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642284087","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642284087?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:45","pubTimestamp":1781181922,"startTime":"0","endTime":"0","summary":"Palisade Bio added Robert Baltera, senior advisor at Frazier Life Sciences, to its board as it advances PALI-2108 toward Phase 2.Baltera previously led Amira Pharmaceuticals as CEO before its 2011 sale to Bristol-Myers Squibb for USD 475 million.Jordan Zwick, co-founder and chief business officer of Mirador Therapeutics, also joined the board.Zwick previously held senior business development and strategy roles at Amarin and InflaRx, with earlier experience at Medtronic.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL3VT5QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","LU0496365809.HKD","LU0211326839.USD","LU0306807586.USD","IE00B64PRP62.GBP","BK4588","IFRX","LU0985481810.HKD","IE00BGHQF631.EUR","LU1093756168.USD","AMRN","LU0882574055.USD","LU1670711040.USD","LU1430594728.SGD","LU2271345857.HKD","LU0006306889.USD","LU1868837136.USD","MDT","IE00BJT1NW94.SGD","LU0070302665.USD","LU1032466523.USD","LU1074936037.SGD","IE00B3QW5Z07.USD","LU1261432733.SGD","BK4533","LU1061106388.HKD","LU1023059063.AUD","LU2210149790.SGD","BK4581","LU2125154778.USD","LU2111349929.HKD","LU0211326755.USD","LU1868837300.USD","LU0321505439.SGD","LU2468319806.SGD","BMY","PALI","LU0211331839.USD","LU0158827948.USD","IE00BKPKM429.USD","IE0009355771.USD","IE00BQXX3F31.USD","BK4585","LU2089283258.USD","NDAQ","LU1323610961.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU0432979614.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634231647","title":"InflaRx price target raised to $8 from $6 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2634231647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634231647?lang=en_us&edition=fundamental","pubTime":"2026-05-12 02:30","pubTimestamp":1778524206,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Matthew Keller raised the firm’s price target on InflaRx (IFRX) to $8 from $6 and keeps a Buy rating on the shares based on...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inflarx-price-target-raised-to-8-from-6-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inflarx-price-target-raised-to-8-from-6-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634239672","title":"InflaRx Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2634239672","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634239672?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:42","pubTimestamp":1778521320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IFRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 13:42 ET (17:42 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634287613","title":"InflaRx Is Maintained at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2634287613","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634287613?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:57","pubTimestamp":1778507820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IFRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 09:57 ET (13:57 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633345632","title":"InflaRx closes USD 150 million follow-on offering of 75,000,000 shares at USD 2 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2633345632","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633345632?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:15","pubTimestamp":1778242525,"startTime":"0","endTime":"0","summary":"InflaRx closed an underwritten follow-on offering of 75,000,000 ordinary shares priced at USD 2 per share.Gross proceeds totaled USD 150 million, before underwriting discounts and offering expenses.Net proceeds earmarked for pipeline development, working capital, general corporate purposes.Deal drew participation from new and existing investors, including TCGX, Farallon Capital Management, Sirenia Capital Management.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL80VdBd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","IE00B64PRP62.GBP","IFRX","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BKPKM429.USD","SG9999014021.USD","BK4588","LU2210150020.SGD","BK4112","NDAQ","LU0314104364.USD","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633456357","title":"Press Release: InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633456357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633456357?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:15","pubTimestamp":1778242500,"startTime":"0","endTime":"0","summary":"Jena, Germany, May 08, 2026  --  InflaRx N.V.  , a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that it has completed its underwritten offering of 75,000,000 ordinary shares of the Company at an offering price of $2.00 per ordinary share. The aggregate gross proceeds from the offering were $150 million, before deducting the underwriting discount and offering expenses.The Company intends to use the net proceeds from the offering to advance its pipeline activities and for working capital and general corporate purposes.The financing included participation from new and existing investors, including TCGX, a large healthcare-dedicated fund, Farallon Capital Management, Sirenia Capital Management LP, Columbia Threadneedle Investments, Great Point Partners, LLC, ADAR1 Capital Management, Coastlands Capital, Squadron Capital Management and other large new mutual funds, with participation from existing investors including a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193016","title":"InflaRx to develop izicopan in AAV","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193016","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633193016?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:51","pubTimestamp":1778125889,"startTime":"0","endTime":"0","summary":"InflaRx (IFRX) announced that it intends to develop izicopan, an oral C5a receptor inhibitor, in AAV, a life-threatening kidney disorder. InflaRx i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inflarx-to-develop-izicopan-in-aav-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inflarx-to-develop-izicopan-in-aav-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633168994","title":"Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633168994","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633168994?lang=en_us&edition=fundamental","pubTime":"2026-05-07 05:25","pubTimestamp":1778102705,"startTime":"0","endTime":"0","summary":"InflaRx NV ::*INFLARX NV: FILES FOR OFFERNG OF ORDINARY SHARES, SIZE NOT DISCLOSED - SEC FILING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-MAY-202621:11:41 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nRSD4K7186:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633276158","title":"InflaRx Gains on Plans for Kidney-Disorder Treatment, $150M Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2633276158","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633276158?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:29","pubTimestamp":1778088540,"startTime":"0","endTime":"0","summary":"Shares of InflaRx rose after the biopharmaceutical company said it is advancing development of izicopan, a kidney-disorder treatment, and said it would raise $150 million through a stock offering.Shares climbed 29%, to $2.54, Wednesday afternoon. The stock has gained about one-and-a-half times its value this year.The company said Wednesday that it was conducting Phase 2 planning for izicopan to treat ANCA-associated vasculitis, a life-threatening form of kidney disease.The German company is also working to establish proof of concept for the drug across other kidney diseases, including atypical hemolytic uremic syndrome, IgA nephropathy and C3 glomerulopathy. It intends to conduct open-label studies that are expected to begin generating clinical data next year.\"We have elected to pursue development in ANCA-associated vasculitis following our thorough evaluation of the high unmet need in this life-threatening disease and izicopan's promise as a significantly differentiated inhibitor of C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"InflaRx Gains on Plans for Kidney-Disorder Treatment, $150M Stock Offering","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633133468","title":"InflaRx prices 75,000,000-share offering at $2, raising $150 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633133468","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633133468?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:32","pubTimestamp":1778070758,"startTime":"0","endTime":"0","summary":"InflaRx priced underwritten follow-on offering of 75,000,000 ordinary shares at USD 2 per share, targeting gross proceeds of USD 150 million.Closing expected May 7, 2026, subject to customary conditions.Net proceeds earmarked for pipeline advancement, working capital, general corporate purposes.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLbfCPWQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IFRX","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633336171","title":"InflaRx targets izicopan development in ANCA-associated vasculitis, plans Phase 2 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2633336171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633336171?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:25","pubTimestamp":1778070321,"startTime":"0","endTime":"0","summary":"InflaRx pivoted izicopan development toward ANCA-associated vasculitis, planning a Phase 2 program while weighing options for a faster regulatory path amid shifting expectations around approved comparator avacopan.Strategy adds open-label renal studies to deliver rapid proof-of-concept data from 2027 in select complement-mediated kidney diseases, including atypical hemolytic uremic syndrome, IgA nephropathy, C3 glomerulopathy.China pharmacokinetic bridging study targeted for 2026 to support broader development plans.Funding runway projected through 2029 to cover Phase 2 AAV readout, proof-of-concept readouts in renal indications, ongoing operations.Capital Markets Day planned for summer 2026 to outline positioning for izicopan across AAV and renal disorders; hidradenitis suppurativa development kept as partner-led option with market potential cited above $1.5 billion per year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL350dwM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4139","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IFRX","IE00BN0W2T93.GBP","NDAQ","BK4112","IE00BN0W2V16.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633382021","title":"InflaRx Q1 2026 net loss narrows to €5.59 million; revenue flat at no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2633382021","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633382021?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:11","pubTimestamp":1778069475,"startTime":"0","endTime":"0","summary":"Inflarx posted a net loss of 5.59 million, or 0.08 a share, for the three months ended March 31, 2026.Operating loss narrowed to 7.21 million from 13.01 million a year earlier.No revenue was recorded, reflecting discontinuation of GOHIBIC  sales activities in the United States in December 2025.Research and development expense fell to 4.17 million from 7.02 million, while general and administrative expense dropped to 3.18 million from 5.06 million.Cash and cash equivalents slipped to 14.99 million at March 31, 2026 from 16.02 million at end-2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inflarx NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syste","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLc8sZSk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633629943","title":"InflaRx NV  expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633629943","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633629943?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:50","pubTimestamp":1777985420,"startTime":"0","endTime":"0","summary":"InflaRx NV  expected to post a loss of14cents a share - Earnings Preview InflaRx NV IFRX.OQ, IFRX.O is expected to  show a rise in quarterly revenue when it reports  results on May 7 for the period en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632951252","title":"Analysts Are Bullish on These Healthcare Stocks: InflaRx (IFRX), Mirum Pharmaceuticals (MIRM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632951252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632951252?lang=en_us&edition=fundamental","pubTime":"2026-05-04 22:50","pubTimestamp":1777906209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InflaRx (IFRX) and Mirum Pharmaceuticals (MIRM) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inflarx-ifrx-mirum-pharmaceuticals-mirm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inflarx-ifrx-mirum-pharmaceuticals-mirm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BLSX","LABU","LU0128526141.USD","BK4139","BK4581","BK4588","MIRM","BK4112","LU0029874061.USD","BLSG","XBI","BK4137","IFRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632121930","title":"InflaRx reports low reactive metabolite formation for izicopan in preclinical liver study","url":"https://stock-news.laohu8.com/highlight/detail?id=2632121930","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632121930?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:32","pubTimestamp":1777894328,"startTime":"0","endTime":"0","summary":"InflaRx disclosed new pre-clinical study results showing izicopan generated fewer potentially harmful reactive metabolites in human liver microsomes than marketed rival avacopan.Findings were presented with this announcement, positioning izicopan as a next-generation oral C5aR1 inhibitor with potential safety differentiation within the class.Data were based on a head-to-head laboratory assay designed to flag early bioactivation-related safety risk, with izicopan showing a more favorable profile than avacopan.InflaRx framed the results as supportive of izicopan’s differentiated profile, while noting in vitro outcomes do not directly predict clinical performance.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL1Q35gq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4112","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","NDAQ","BK4585","LU2095319765.USD","BK4588","BK4139","IE00BN0W2W23.USD","LU0314104364.USD","IFRX","IE00BN0W2V16.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632108126","title":"InflaRx NV  expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632108126","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632108126?lang=en_us&edition=fundamental","pubTime":"2026-05-01 21:48","pubTimestamp":1777643286,"startTime":"0","endTime":"0","summary":"InflaRx NV  expected to post a loss of14cents a share - Earnings Preview InflaRx NV IFRX.OQ, IFRX.O is expected to  show a rise in quarterly revenue when it reports  results on May 7 for the period en","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL8N41E14P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632113196","title":"InflaRx to report first-quarter results before market open, no conference call planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2632113196","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632113196?lang=en_us&edition=fundamental","pubTime":"2026-05-01 19:30","pubTimestamp":1777635044,"startTime":"0","endTime":"0","summary":"InflaRx will publish first-quarter 2026 financial and operating results on May 7, 2026, before market open.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL66M7KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","IFRX","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4139","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630067993","title":"InflaRx regains Nasdaq compliance after shares hold above $1 minimum bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2630067993","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630067993?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:39","pubTimestamp":1777376359,"startTime":"0","endTime":"0","summary":"InflaRx regained compliance with Nasdaq minimum bid price rule 5450, removing risk of a potential delisting process tied to its share price.Nasdaq notified InflaRx on April 27 that the stock closed at $1 or higher for 10 consecutive business days from April 13 to April 24.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL759J95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BKPKM429.USD","IFRX","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","BK4585","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4139","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","BK4588","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629803754","title":"InflaRx Price Target Maintained With a $14.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2629803754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629803754?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:48","pubTimestamp":1776779280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IFRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2026 09:48 ET (13:48 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}